KIMS Q2 FY27 ; CONS NET PROFIT UP 3.61% AT ₹74.60 CR (YOY), UP 99.47% (QOQ)

REVENUE UP 39.94% AT ₹1,344.40 CR (YOY), UP 13.98% (QOQ) EBITDA UP 27.60% AT ₹260.30 CR (YOY), UP 16.36% (QOQ) MARGINS AT 19.36% VS 21.23% (YOY), 18.97% (QOQ)

KRISHNA INST OF MED SCI L

← Back to feed